High-dose interleukin-2 (hd-IL2) in treatment-naïve metastatic renal cell carcinoma (mrcc) - a 10 year single-site experience and outcome of prospective pathology-based patient selection.
| Image |  |
|---|---|
| Description | scientific article published on 6 November 2014 |
| Author/s |
author: Fiona Thistlethwaite |
| Publication date | November 6, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |